Quimno, Onofre G.
HRN: 22-85-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/18/2024
07/25/2024
IV
4.5gram
Q8
Sepsis Secondary To Infected Pressure Ulcer
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes